Probiotics in Cancer Prevention

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 497-511

  de LeBlanc, Alejandra de Moreno ^a   Bibas Bonet, María Eugenia ^b   LeBlanc, Jean Guy ^a   Sesma, Fernando ^a   Perdigón, Gabriela ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884452435     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374938-3.00029-3     Document Type: Chapter

References (76)

1. Kato I. Antitumor activity of lactic acid bacteria. Probiotics 3: Immunomodulation by the gut microflora and probiotics 2000, 115-138. Kluwer Academic Publishers, London. R. Fuller, G. Perdigon (Eds.).
2. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. The Journal of Nutrition 2000, 130:396S-402S.
3. Hughes R., Rowland I. Nutritional and microbial modulation of carcinogenesis. Gut flora, nutrition, immunity and health 2003, 208-236. Blackwell Publishing, Oxford. R. Fuller, G. Perdign (Eds.).
4. Kato I., Yokokura T., Mutai M. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiology and Immunology 1984, 28:209-217.
5. Hayashi K., Ohwaki M. Antitumour activity of Lactobacillus casei (LC 9018) in mice: T cell subset depletion. Biotherapy 1989, 3:1568-1574.
6. Fernandes C.F., Shahan K.M. Anticarcinogenic and immunological properties of dietary lactobacilli. Journal of Food Protection 1990, 53:704-710.
7. Brady L.J., Gallaher D.D., Busta F.F. The role of probiotic cultures in the prevention of colon cancer. The Journal of Nutrition 2000, 130:410S-414S.
8. Wollowski I., Rechkemmer G., Pool-Zobel B.L. Protective role of probiotics and prebiotics in colon cancer. The American Journal of Clinical Nutrition 2001, 73:451S-455S.
9. Orrhage K.M., Annas A., Nord C.E., et al. Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice. Scandinavian Journal of Gastroenterology 2002, 37:215-221.
10. Morotomi M., Mutai M. In vitro binding of potent mutagenic pyrolysates to intestinal bacteria. Journal of the National Cancer Institute 1986, 77:195-201.
11. Goldin B.R., Swenson L., Dwyer J., et al. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. Journal of the National Cancer Institute 1980, 64:255-261.
12. Goldin B.R., Gorbach S.L. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. The American Journal of Clinical Nutrition 1984, 39:756-761.
13. Goldin B.R., Gorbach S.L. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. Journal of the National Cancer Institute 1980, 64:263-265.
14. Goldin B.R., Gorbach S.L. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. Journal of the National Cancer Institute 1976, 57:371-375.
15. Geier M.S., Butler R.N., Howarth G.S. Probiotics, prebiotics and synbiotics: A role in chemoprevention for colorectal cancer?. Cancer Biology & Therapy 2006, 5:1265-1269.
16. Reddy G.V., Friend B.A., Shahani K.M., Farmer R.E. Antitumor activity of yogurt components. Journal of Food Protection 1983, 46:8-11.
17. Perdigon G., Fuller R., Raya R. Lactic acid bacteria and their effect on the immune system. Current Issues in Intestinal Microbiology 2001, 2:27-42.
18. Le M.G., Moulton L.H., Hill C., Kramar A. Consumption of dairy produce and alcohol in a case-control study of breast cancer. Journal of the National Cancer Institute 1986, 77:633-636.
19. Peters R.K., Pike M.C., Garabrant D., Mack T.M. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992, 3:457-473.
20. van't Veer P., Dekker J.M., Lamers J.W., et al. Consumption of fermented milk products and breast cancer: A case-control study in The Netherlands. Cancer Research 1989, 49:4020-4023.
21. Aso Y., Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP study group. Urologia Internationalis 1992, 49:125-129.
22. Perdigon G., Valdez J.C., Rachid M. Antitumor activity of yogurt: Study of possible immune mechanisms. The Journal of Dairy Research 1998, 65:129-138.
23. Perdigon G., Rachid M., De Budeguer M.V., Valdez J.C. Effect of yogurt feeding on the small and large intestine associated lymphoid cells in mice. The Journal of Dairy Research 1994, 61:553-562.
24. Valdez J.C., Rachid M., Bru E., Perdign G. The effect of yogurt on the cytotoxic and phagocytic activity of macrophages in tumor-bearing mice. Food and Agricultural Immunology 1997, 9:299-308.
25. Perdigon G., de Moreno de LeBlanc A., Valdez J., Rachid M. Role of yogurt in the prevention of colon cancer. European Journal of Clinical Nutrition 2002, 56(Suppl. 3):S65-S68.
26. Isaacson P. Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut 1982, 23:578-588.
27. Prescott S.M., Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochimica et Biophysica Acta 2000, 1470:M69-M78.
28. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Frontiers in Bioscience 1997, 2:d12-d26.
29. Weitzman S.A., Gordon L.I. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 1990, 76:655-663.
30. Korelitz B.I. Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileitis and colitis. The American Journal of Gastroenterology 1983, 78:44-46.
31. Collins R.H., Feldman M., Fordtran J.S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. The New England Journal of Medicine 1987, 316:1654-1658.
32. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. The New England Journal of Medicine 1990, 323:1228-1233.
33. Reddy B.S., Maruyama H., KelloffG. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Research 1987, 47:5340-5346.
34. Lala P.K., Parhar R.S., Singh P. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunology 1986, 99:108-118.
35. de Moreno de LeBlanc A., Valdez J., Perdigón G. Inflammatory immune response. European Journal of Inflammation 2004, 2:21-31.
36. de Moreno de Leblanc A., Perdigon G. Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Medical Science Monitor 2004, 10:BR96-BR104.
37. Bogdan C., RollinghoffM., Diefenbach A. The role of nitric oxide in innate immunity. Immunological Reviews 2000, 173:17-26.
38. Butler L.M., Hewett P.J., Fitridge R.A., Cowled P.A. Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. The Australian and New Zealand Journal of Surgery 1999, 69:88-94.
39. Hao X., Du M., Bishop A.E., Talbot I.C. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Archiv 1998, 433:523-527.
40. Sellers W.R., Fisher D.E. Apoptosis and cancer drug targeting. The Journal of Clinical Investigation 1999, 104:1655-1661.
41. Rachid M.M., Gobbato N.M., Valdez J.C., et al. Effect of yogurt on the inhibition of an intestinal carcinoma by increasing cellular apoptosis. International Journal of Immunopathology and Pharmacology 2002, 15:209-216.
42. de Moreno de LeBlanc A., Perdigon G. Reduction of beta-glucuronidase and nitroreductase activity by yogurt in a murine colon cancer model. Biocell 2005, 29:15-24.
43. Perdigón G., de Jorrat M., Valdez J., et al. Cytolytic effect of the serum of mice fed with Lactobacillus casei on tumor cell. Microbiologie-Aliments-Nutrition 1995, 13:15-24.
44. Perdigón G., de Jorrat M., de Petrino S., Rachid M. Antitumor activity of orally administered L. casei. Significance of its dose in the inhibition of a fibrosarcoma in mice. Food and Agricultural Immunology 1993, 5:39-49.
45. Bibas Bonet M.E., Fontenla S., Mesón O., Perdigón G. Antitumoral effect of L. casei CRL 431 on different experimental tumors. Food and Agricultural Immunology 2005, 16:181-191.
46. Perdigón G., Medici M., de Jorrat M., et al. Immunomodulation effect of lactic acid bacteria on mucosal and tumor immunity. International Journal of Immunotherapy 1993, IX:29-52.
47. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. The Journal of Biological Chemistry 1997, 272:20313-20316.
48. Farr S.B., Kogoma T. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiological Reviews 1991, 55:561-585.
49. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 1991, 51:794-798.
50. Kruidenier L., van Meeteren M.E., Kuiper I., et al. Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radical Biology & Medicine 2003, 34:753-765.
51. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Alimentary Pharmacology & Therapeutics 2002, 16:1997-2015.
52. Lih-Brody L., Powell S.R., Collier K.P., et al. Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Digestive Diseases and Sciences 1996, 41:2078-2086.
53. Abriouel H., Herrmann A., Starke J., et al. Cloning and heterologous expression of hematin-dependent catalase produced by Lactobacillus plantarum CNRZ 1228. Applied and Environmental Microbiology 2004, 70:603-606.
54. Knauf H.J., Vogel R.F., Hammes W.P. Cloning, sequence, and phenotypic expression of katA, which encodes the catalase of Lactobacillus sake LTH677. Applied and Environmental Microbiology 1992, 58:832-839.
55. Noonpakdee W., Sitthimonchai S., Panyim S., Lertsiri S. Expression of the catalase gene katA in starter culture Lactobacillus plantarum TISTR850 tolerates oxidative stress and reduces lipid oxidation in fermented meat product. International Journal of Food Microbiology 2004, 95:127-135.
56. Rochat T., Gratadoux J.J., Gruss A., et al. Production of a heterologous nonheme catalase by Lactobacillus casei: An efficient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Applied and Environmental Microbiology 2006, 72:5143-5149.
57. Rochat T., Miyoshi A., Gratadoux J.J., et al. High-level resistance to oxidative stress in Lactococcus lactis conferred by Bacillus subtilis catalase KatE. Microbiology 2005, 151:3011-3018.
58. de Moreno de LeBlanc A., LeBlanc J.G., Perdigón G., et al. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. Journal of Medical Microbiology 2008, 58:100-105.
59. Rochat T., Bermudez-Humaran L., Gratadoux J.J., et al. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependent catalase on DSS-induced colitis in mice. Microbial Cell Factories 2007, 6:22.
60. Sanders J.W., Leenhouts K.J., Haandrikman A.J., et al. Stress response in Lactococcus lactis: cloning, expression analysis, and mutation of the lactococcal superoxide dismutase gene. Journal of Bacteriology 1995, 177:5254-5260.
61. Ogawa Y., Kanatsu K., Iino T., et al. Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Science 2002, 71:827-839.
62. Segui J., Gironella M., Sans M., et al. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. Journal of Leukocyte Biology 2004, 76:537-544.
63. Divisi D., Di Tommaso S., Salvemini S., et al. Diet and cancer. Acta Bio-medica 2006, 77:118-123.
64. Donaldson M.S. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutrition Journal 2004, 3:19.
65. Matar C., LeBlanc J.G., Martin L., Perdigon G. Biologically active peptides released from fermented milk: Role and functions. Handbook of fermented functional foods 2003, 177-201. CRC Press, Boca Raton, FL. E. Farnworth (Ed.).
66. LeBlanc J.G., Matar C., Valdez J.C., et al. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. Journal of Dairy Science 2002, 85:2733-2742.
67. Reome J.B., Hylind J.C., Dutton R.W., Dobrzanski M.J. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Clinical Immunology 2004, 111:69-81.
68. Zhang G., Li W., Holle L., et al. A novel design of targeted endocrine and cytokine therapy for breast cancer. Clinical Cancer Research 2002, 8:1196-1205.
69. Reed M.J., Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis. Endocrine Reviews 1997, 18:701-715.
70. de Moreno de LeBlanc A., Matar C., LeBlanc N., Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Research 2005, 7:R477-R486.
71. Ferrarini M., Ferrero E., Dagna L.P.A., Zocchi M.R. Human gamma/delta T cell: A nonredundant system in the immune-surveillance against cancer. Trends in Immunolology 2002, 23:14-18.
72. Bingle L., Brown N.J., Lewis C.E. The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. The Journal of Pathology 2002, 196:254-265.
73. Purohit A., Newman S.P., Reed M.J. The role of cytokines in regulating estrogen synthesis: Implications for the etiology of breast cancer. Breast Cancer Research 2002, 4:65-69.
74. Urban J.L., Shepard H.M., Rothstein J.L., et al. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proceedings of the National Academy of Sciences of the United States of America 1986, 83:5233-5237.
75. de Moreno de LeBlanc A., Matar C., Theriault C., Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 2005, 210:349-358.
76. Steidler L., Hans W., Schotte L., et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289:1352-1355.